» Articles » PMID: 32308567

Caco-2 Cells for Measuring Intestinal Cholesterol Transport - Possibilities and Limitations

Overview
Publisher Biomed Central
Date 2020 Apr 21
PMID 32308567
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The human Caco-2 cell line is a common in vitro model of the intestinal epithelial barrier. As the intestine is a major interface in cholesterol turnover and represents a non-biliary pathway for cholesterol excretion, Caco-2 cells are also a valuable model for studying cholesterol homeostasis, including cholesterol uptake and efflux. Currently available protocols are, however, either sketchy or not consistent among different laboratories. Our aim was therefore to generate a collection of optimized protocols, considering the different approaches of the different laboratories and to highlight possibilities and limitations of measuring cholesterol transport with this cell line.

Results: We developed comprehensive and quality-controlled protocols for the cultivation of Caco-2 cells on filter inserts in a single tight monolayer. A cholesterol uptake as well as a cholesterol efflux assay is described in detail, including suitable positive controls. We further show that Caco-2 cells can be efficiently transfected for luciferase reporter gene assays in order to determine nuclear receptor activation, main transcriptional regulators of cholesterol transporters (ABCA1, ABCB1, ABCG5/8, NPC1L1). Detection of protein and mRNA levels of cholesterol transporters in cells grown on filter inserts can pose challenges for which we highlight essential steps and alternative approaches for consideration. A protocol for viability assays with cells differentiated on filter inserts is provided for the first time.

Conclusions: The Caco-2 cell line is widely used in the scientific community as model for the intestinal epithelium, although with highly divergent protocols. The herein provided information and protocols can be a common basis for researchers intending to use Caco-2 cells in the context of cellular cholesterol homeostasis.

Citing Articles

GelMA as scaffold material for epithelial cells to emulate the small intestinal microenvironment.

Roegiers I, Gheysens T, Minsart M, De Clercq P, Vanbeversluys K, Rac N Sci Rep. 2025; 15(1):8214.

PMID: 40064943 PMC: 11893807. DOI: 10.1038/s41598-024-81533-5.


Enhanced intestinal epithelial co-culture model with orbital mechanical stimulation: a proof-of-concept application in food nanotoxicology.

Santoni M, Piccinini G, Liguori G, Randi M, Baroncini M, Milani L Front Mol Biosci. 2025; 11:1529027.

PMID: 39872165 PMC: 11769796. DOI: 10.3389/fmolb.2024.1529027.


Improving the Accuracy of Permeability Data to Gain Predictive Power: Assessing Sources of Variability in Assays Using Cell Monolayers.

Pires C, Moreno M Membranes (Basel). 2024; 14(7).

PMID: 39057665 PMC: 11278619. DOI: 10.3390/membranes14070157.


Reprogramming human urine cells into intestinal organoids with long-term expansion ability and barrier function.

Zhang R, Chen Y, Feng Z, Cai B, Cheng Y, Du Y Heliyon. 2024; 10(13):e33736.

PMID: 39040281 PMC: 11261862. DOI: 10.1016/j.heliyon.2024.e33736.


Whey Protein Sodium-Caseinate as a Deliverable Vector for EGCG: In Vitro Optimization of Its Bioaccessibility, Bioavailability, and Bioactivity Mode of Actions.

Korin A, Gouda M, Youssef M, Elsharkawy E, Albahi A, Zhan F Molecules. 2024; 29(11).

PMID: 38893466 PMC: 11174060. DOI: 10.3390/molecules29112588.


References
1.
Gombert M, Carrasco-Luna J, Pin-Arboledas G, Codoner-Franch P . The connection of circadian rhythm to inflammatory bowel disease. Transl Res. 2019; 206:107-118. DOI: 10.1016/j.trsl.2018.12.001. View

2.
Morel E, Demignot S, Chateau D, Chambaz J, Rousset M, Delers F . Lipid-dependent bidirectional traffic of apolipoprotein B in polarized enterocytes. Mol Biol Cell. 2003; 15(1):132-41. PMC: 307534. DOI: 10.1091/mbc.e03-04-0215. View

3.
FIELD F, ALBRIGHT E, Mathur S . Regulation of triglyceride-rich lipoprotein secretion by fatty acids in CaCo-2 cells. J Lipid Res. 1988; 29(11):1427-37. View

4.
Lalloyer F, Fievet C, Lestavel S, Torpier G, van der Veen J, Touche V . The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia. Arterioscler Thromb Vasc Biol. 2006; 26(12):2731-7. DOI: 10.1161/01.ATV.0000248101.93488.84. View

5.
Yamaura Y, Chapron B, Wang Z, Himmelfarb J, Thummel K . Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-Pass Metabolism. Drug Metab Dispos. 2015; 44(3):329-35. PMC: 4767385. DOI: 10.1124/dmd.115.068429. View